Research focuses on targeted protein degradation and antibody-drug conjugate as promising modalities for developing next-generation cancer therapies that may improve patient outcomes SEOUL, South Korea — Agilent Technologies Inc. (NYSE: A) announced the recent signing of a Memorandum of Understanding (MOU) with Ubix Therapeutics to accelerate highly targeted cancer therapy research and development in South Korea over […]
PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it has reached a settlement agreement with Bruker Corporation, successfully resolving all outstanding worldwide patent litigation and disputes between the two companies. As part of the settlement, 10x expects that Bruker will pay $68 million in equal quarterly installments between […]
ST. PAUL, Minn. — ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady announced today three G-Rex Grants that have been awarded to faculty members at the University of Southern California (USC) and the Children’s Hospital of Los Angeles (CHLA). The funding totaling $1,025,000 will support the translation of various cell and […]
BILLERICA, Mass. — Bruker Corporation (Nasdaq: BRKR) today announced that Bruker and 10x Genomics have reached a final settlement to resolve their patent disputes and dismiss multiple litigations, with global patent cross license agreements between the two companies. In connection with the settlement, all ongoing lawsuits and administrative proceedings filed by both companies in several countries, including […]
ALAMEDA, Calif. and PRINCETON, N.J. — CellFE, a leader in microfluidics-based cell engineering, and Made Scientific, a leading cell therapy contract development and manufacturing organization (CDMO), today announced a strategic collaboration to generate pilot data on the CellFE High Volume Cyva™ System. This partnership will validate the clinical-scale performance of CellFE’s innovative, non-viral gene editing microfluidics technology for both activated […]
New assay delivers high-resolution whole transcriptome data to explore biology beyond known genes PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced the launch of Visium HD 3’ Gene Expression, a powerful new assay that expands the capabilities of the Visium HD portfolio beyond the boundaries of known […]
ANN ARBOR, Mich. — Akadeum Life Sciences, a leader in buoyancy-based cell separation technology, announces the broad integration capability of its flagship product, microbubble-based cell separation. Microbubble integration into existing platforms enables scaled-up centralized and decentralized cell therapies, reducing footprint and cost. By leveraging microbubble technology, users gain a reduced footprint for cell therapy manufacturing, seamless integration, and healthier cells. Akadeum is […]
New BD FACSDiscover™ A8 Cell Analyzer Brings Leading-Edge Capabilities to Wider Range of Scientists across Academia and Biopharma FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the global commercial launch of the world’s first cell analyzer featuring breakthrough spectral and real-time cell imaging technologies, enabling more […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its latest spatial biology and cell and gene therapy workflow solutions at the American Society of Gene & Cell Therapy (ASGCT) 2025 meeting taking place in New Orleans between May 13th – 17th at the New Orleans Ernest N. Morial Convention Center. Bio-Techne will feature its cutting-edge […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its latest spatial biology and cell and gene therapy workflow solutions at the American Society of Gene & Cell Therapy (ASGCT) 2025 meeting taking place in New Orleans between May 13th – 17th at the New Orleans Ernest N. Morial Convention Center. Bio-Techne will feature its cutting-edge […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
